Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study

BACKGROUND: Mizoribine (MZR) is an immunosuppressive agent that selectively inhibits inosine monophosphate dehydrogenase; its actions are considerably similar to those of mycophenolate mofetil (MMF). This study aimed to clarify whether MZR can be a good treatment option for systemic lupus erythemato...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayano, Masahiro, Kimoto, Yasutaka, Mitoma, Hiroki, Akahoshi, Mitsuteru, Ono, Nobuyuki, Arinobu, Yojiro, Akashi, Koichi, Horiuchi, Takahiko, Niiro, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109492/
https://www.ncbi.nlm.nih.gov/pubmed/35586513
http://dx.doi.org/10.1177/1759720X221096367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109492/
https://www.ncbi.nlm.nih.gov/pubmed/35586513
http://dx.doi.org/10.1177/1759720X221096367

Ejemplares similares